[Possibility of damage to blood vessel walls due to intravenous anesthetics. Clinical and experimental study].
D000328:Adult; D000530:Alfaxalone Alfadolone Mixture / Q000009:adverse effects; D000771:Anesthesia, Intravenous / Q000009:adverse effects*; D000777:Anesthetics / Q000009:adverse effects*; D000818:Animals; D001285:Atropine / Q000009:adverse effects; D001808:Blood Vessels / Q000187:drug effects*; D002368:Castor Oil / Q000009:adverse effects*; D003975:Diazepam / Q000009:adverse effects; D005260:Female; D005990:Glycerol / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D010689:Phlebitis / Q000139:chemically induced; D011229:Preanesthetic Medication / Q000009:adverse effects*; D011410:Propanidid / Q000009:adverse effects; D011817:Rabbits; D013924:Thrombophlebitis / Q000139:chemically induced; D013927:Thrombosis / Q000139:chemically induced; D014652:Vascular Diseases / Q000139:chemically induced*
D000777:Anesthetics; C000515:cremophor EL; D001285:Atropine; D002368:Castor Oil; D000530:Alfaxalone Alfadolone Mixture; D011410:Propanidid; D005990:Glycerol; D003975:Diazepam
Sulla possibilità di danni alla parete vasale da anestetici endovenosi. Studio clinico e superimentale.